Search for: "Astrazeneca PLC"
Results 1 - 20
of 95
Sort by Relevance
|
Sort by Date
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
23 Jul 2022, 1:54 pm
Sommer: My Holiday Wish List From the PTO (Source: SSRN) New Job Postings on Patently-O: Neustel Law Offices, LTD Harrity & Harrity, LLP – Patent Drafting Professionals and/or Agents Bejin Bieneman PLC Viering, Jentschura & Partner Fiala & Weaver P.L.L.C. [read post]
11 Jan 2022, 11:45 am
In 2015, AstraZeneca and Cephalon paid a total of $54 million to resolve claims that they also improperly reduced AMPs by wrongfully accounting for service fees they paid to wholesalers. [read post]
11 Jan 2022, 11:45 am
In 2015, AstraZeneca and Cephalon paid a total of $54 million to resolve claims that they also improperly reduced AMPs by wrongfully accounting for service fees they paid to wholesalers. [read post]
27 Jan 2021, 1:44 pm
-based biopharma firm AstraZeneca plc relating to the setbacks the company encountered late last year in connection with the company’s efforts to develop a COVID-19 vaccine. [read post]
1 Oct 2020, 12:12 pm
Mahaffy, September 29, 2020, Jackson, R.).Clovis was in close competition with AstraZeneca PLC to develop a drug to treat lung cancer. [read post]
19 Feb 2020, 1:03 pm
Federal Trade Commission (“FTC”) raising concerns that the divestiture of Allergan plc’s (“Allergan”) pipeline drug, brazikumab, will not succeed unless the FTC addresses AbbVie’s use of rebate walls. [read post]
7 Oct 2019, 10:59 am
The heart of the case appeared to be that Clovis was in close competition with AstraZeneca PLC to develop rival drugs to treat otherwise untreatable forms of lung cancer. [read post]
20 May 2019, 9:13 am
Michael Handler: Trademark Transactions in Common Law Countries: Liberalisation and Its Limits (Source: SSRN) New Job Postings on Patently-O: Ballard Spahr LLP–Part-Time Patent Associate or Agent MH2 Technology Law Group, LLP DiBerardino McGovern IP Group Ballard Spahr LLP–IP Attorney or Agent Saint Gobain North America Intellectual Property Owners Association The Kudelski Group Bejin Bieneman, PLC Caldwell Intellectual Property Law Dority & Manning AstraZeneca… [read post]
1 Nov 2018, 6:26 am
The warning applies to the class of SGLT2 inhibitors, specifically, Johnson & Johnson’s Invokana (canagliflozin), AstraZeneca Plc’s Farxiga (dapagliflozin), and Eli Lilly & Co. [read post]
1 Dec 2017, 11:35 am
.), AstraZeneca (U.S), Roche (Switzerland) and Aimmune Therapeutics (U.S.). [read post]
6 Jul 2017, 9:30 pm
AstraZeneca Plc, the appellant in the case, reportedly argued that the doctrine made it too easy for drug companies to lose patents. [read post]
12 May 2017, 9:05 am
., AstraZeneca Pharmaceuticals LP, AstraZeneca LP, AstraZeneca PLC, and AstraZeneca AB (collectively, Bristol-Myers/AstraZeneca), which developed, manufactured, and marketed the drugs, failed to adequately test the drugs and warn of their risks. [read post]
3 Apr 2017, 10:55 pm
(T-321/05 AstraZeneca v Commission [2010] ECR II-2805). [read post]
6 Mar 2017, 10:01 am
“Our chief scientific officer is a former MedImmune/AstraZeneca plc (ADR) (NYSE: AZN) director. [read post]
16 Aug 2016, 7:57 am
Once was ahead of the company’s announcement of an agreement to license a cancer drug and the second was in advance of its acquisition by AstraZeneca PLC. [read post]
11 Aug 2016, 2:29 pm
The Ardea employee tipped one of the brokers ahead of the company’s announcement of an agreement to license a cancer drug and later tipped him in advance of its acquisition by AstraZeneca PLC. [read post]
13 Apr 2015, 2:51 pm
As regards what that FDA staff document contained and its significance, from an April 10, 2015 Bloomberg news report, "AstraZeneca’s Diabetes Drug May Raise Death Risk, FDA Says": AstraZeneca Plc’s type 2 diabetes drug Onglyza showed an increased risk of death in an analysis by U.S. regulators of a clinical trial on the heart effects of the treatment. [read post]
25 Feb 2015, 5:00 am
Astrazeneca Pharmaceuticals PLC, 2013 ONSC 1169, the Charlton decision demonstrates a shift to a stricter and more thorough analysis of proposed class action claims. [read post]
3 Dec 2014, 5:19 am
"AstraZeneca Fights Billions in Possible Nexium Damages": Erik Larson and Janelle Lawrence of Bloomberg News have a report that begins, "AstraZeneca Plc, in a first trial since the U.S. [read post]
